<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04640350</url>
  </required_header>
  <id_info>
    <org_study_id>S2020-387-02</org_study_id>
    <nct_id>NCT04640350</nct_id>
  </id_info>
  <brief_title>Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography</brief_title>
  <official_title>Risk Prediction of Bleeding in Liver Cirrhosis by Combi-elastography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Through the parameters of liver stiffness and spleen stiffness obtained by combi-elastography&#xD;
      technique, summarize and analyze the warning index of esophagogastric variceal bleeding in&#xD;
      patients with cirrhosis, so as to provide a new and valuable technique for clinical&#xD;
      diagnosis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Firstly,the combi-elastography technique developed by HITACHI uses the method of multi-index&#xD;
      and multi-parameter to evaluate the liver stiffness and spleen stiffness comprehensively.&#xD;
&#xD;
      And then,this prospective study is designed to follow up patients with cirrhosis for a period&#xD;
      of 12 months, summarize and analyze the warning index of bleeding in patients with&#xD;
      cirrhosis,so as to provide a new and valuable technique for clinical diagnosis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 31, 2020</start_date>
  <completion_date type="Anticipated">May 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>F index</measure>
    <time_frame>baseline</time_frame>
    <description>F index is linked to the degree of liver fibrosis,and it can be available by ultrasound elastography checking.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>A index</measure>
    <time_frame>baseline</time_frame>
    <description>A index is linked to the degree of hepatitis ,and it can be available by ultrasound elastography checking.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Spleen stiffness</measure>
    <time_frame>baseline</time_frame>
    <description>Spleen stiffness can be available by ultrasound elastography checking.</description>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Liver Cirrhosis</condition>
  <condition>Gastroesophageal Varices</condition>
  <condition>Variceal Hemorrhage</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with liver cirrhosis and the gastroscopy is in line with the indications of portal&#xD;
        hypertension.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18-80 years old, no gender limit;&#xD;
&#xD;
          -  The clinical diagnosis is in line with patients with liver cirrhosis caused by chronic&#xD;
             hepatitis B, and the gastroscopy is in line with the indications of portal&#xD;
             hypertension;&#xD;
&#xD;
          -  Gastroscopy needs to provide the degree of gastroesophageal varices;&#xD;
&#xD;
          -  Sign the informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with cirrhosis and portal hypertension because of other causes or combined&#xD;
             with other causes(such as viral hepatitis other than hepatitis B,Autoimmune liver&#xD;
             disease, alcoholic liver disease, metabolism-related fatty liver disease, etc.)&#xD;
&#xD;
          -  Patients with a history of spleen-related operations, such as splenectomy, splenic&#xD;
             embolism;&#xD;
&#xD;
          -  Patients undergoing portosystemic shunt or TIPS;&#xD;
&#xD;
          -  Isolated esophageal venous tumor and its bleeding patients;&#xD;
&#xD;
          -  History of upper gastrointestinal tumor or bleeding from gastric ulcer , etc;&#xD;
&#xD;
          -  Those with serious diseases of other systems that cannot cooperate with elastography&#xD;
             examination, such as heart failure, renal failure, mental illness, etc;&#xD;
&#xD;
          -  Ascites before liver and spleen result unable to complete elasticity examination;&#xD;
&#xD;
          -  Pregnant patients.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ping Liang, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese PLA General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jie Yu, Doctor</last_name>
    <phone>010-66937981</phone>
    <email>yu-jie301@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chinese PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ping Liang, Doctor</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>November 10, 2020</study_first_submitted>
  <study_first_submitted_qc>November 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 23, 2020</study_first_posted>
  <last_update_submitted>January 13, 2021</last_update_submitted>
  <last_update_submitted_qc>January 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Ping Liang</investigator_full_name>
    <investigator_title>Chief physician</investigator_title>
  </responsible_party>
  <keyword>Elasticity Imaging Techniques</keyword>
  <keyword>Ultrasound</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

